| |
Statement of purpose Since its inception, the International Journal of Gynecology & Obstetrics (IJGO) has had two
primary purposes:
(1) to serve an international audience by publishing original scientific articles and communications originating
in low-income countries which emphasize important obstetric and gynecologic problems, issues, and perspectives, such as maternal mortality
and family planning; as well as publishing original articles and communications from the scientific community of high-income countries,
with particular emphasis on sharing advances in the specialty of obstetrics and gynecology; and
(2) to further the organizational
purposes of the International Federation of
Gynecology and Obstetrics (FIGO) by providing a means of bringing to the readership decisions
of the officers and executive board, reports of the standing committees of FIGO, and information from the FIGO Secretariat in the intervals
between meetings of the executive board and the international congresses; and by providing information from the World Health Organization
and those other important international organizations that deal with women's health and the specialty of obstetrics and gynecology.
Conflict of interest. All authors must sign the Author(s) Guarantee Form (available online at submission) and include a statement
in the cover letter and before the reference section in the article itself to declare any conflicts of interest. The author(s) must guarantee: (1) that the article has not been published elsewhere; (2) it is not being considered for publication elsewhere; and (3) that it has
been submitted with the full knowledge and approval of the institution or organization given as the affiliation of the author(s).
Submission of multi-authored manuscripts implies the consent of each of the authors.
Submission. Authors must submit manuscripts
online using the Elsevier Editorial Submission System (EES): ees.elsevier.com/ijg.
Hard copy submissions will not be considered or returned. Once submitted, manuscripts undergo initial screening by the editorial staff
and editors. To ensure timely processing of the high number of submissions received, papers that do not meet the journal's requirements
will be declined at this stage, without peer review, and the authors will receive prompt notification. All other papers will be peer
reviewed.
Authors must register using EES when submitting a manuscript, at which time they will be given a login and password for
access to their Home Page (please remember this information and avoid creating duplicate accounts). Authors should send queries concerning
the submission process or journal procedures to authorsupport@elsevier.com. Authors can check the status of their manuscript
within the review process using EES. All correspondence, including notification of the Editor's decision and requests for revision, takes
place by e-mail and via the Author's homepage.
Guidelines for types of articles
Randomized Controlled Trials (RCTs).
Submission of RCTs must include reference to ethics approval (or explanation of why ethics approval was not received). Authors must consult
CONSORT checklist guidelines ( http://www.consort-statement.org/consort-statement) and include a flow chart as a Figure with
the manuscript.
Clinical trial registration: Authors are strongly encouraged to register clinical trials in free, public clinical
trial registries. As a condition of consideration for publication, this requirement will be compulsory for all RCTs submitted after January
1, 2012. The clinical trial registration should be included at the end of the abstract.
Systematic reviews based on the
following recommended guidelines and checklists will be given preference. Authors of meta-analysis or systematic review of RCTs should
consult the QUOROM guidelines and checklist:
www.consort-statement.org/QUOROM.
Authors of meta-analysis of observational studies should consult the MOOSE guidelines and checklist: www.consort-statement.org/MOOSE.
Useful resource
The EQUATOR Network website ( http://www.equator-network.org/home)
explains what reporting guidelines are and why they are needed. It contains links to the checklists described above and provides useful
guidance for authors and editors.
Layout of manuscripts
Full-length clinical articles should not exceed 2500
words in the body of text, excluding the title page, abstract (no more than 200 words), synopsis, keywords, figure legends, tables
and figures, acknowledgments, and references (no more than 25). Please include the word count in the cover letter and on the title page
of the manuscript. Subject matter should be organized under suitable headings such as Structured Abstract, Introduction, Materials
and methods, Results, Discussion, Acknowledgments, and References. Footnotes should be avoided and their contents incorporated
into the text. The first page should contain: (a) title; (b) full name(s) of author(s); (c) affiliation(s) of author(s) (i.e.
department, section or unit of an institution, hospital or organization, city, state and/or country where it is located (please note
street numbers and name are not required); (d) full contact details of the corresponding author; (e) a list of 3-6 keywords for indexing
and retrieval; (f) synopsis no longer than 25 words, stating in one or two sentences the conclusions of the paper. The reference list
should not exceed 25 references. Papers are published in English, using American spelling. The editors reserve the right to make any
necessary editorial changes. Clinical research should include a statement that the study has been approved by the Institutional Review
Board or other appropriate body.
Systematic review articles should adhere to QUOROM or MOOSE guidelines, with no more than
3000-3500 words and 40 references. A structured abstract of no more than 200 words is required and should include the following sections: Background; Objectives; Search Strategy; Selection criteria; Data collection and analysis; Main results; Conclusions.
Brief
communications (including case reports) should be no more than 400 words in the body of text, excluding synopsis, keywords, figure
legends, tables and figures, and references. There should be no more than 4 references, no more than 1 table or 1 figure, and no more
than 3 authors.
Submission requirements The names of all authors should be listed on the Author(s) Guarantee Form, which
is available at submission. There should also be a transmittal letter. After the article has been accepted for publication, the name
of each author must also be listed on a Transfer of Copyright assigning the International Federation of Gynecology and Obstetrics all
rights to the manuscript to protect the author(s) and the IJGO from unauthorized use of the article's contents. The article's principal
author is responsible for ensuring that all the necessary forms are completed.
Uniform requirements. The requirements of
the International Journal of Gynecology & Obstetrics are in accordance with the Uniform Requirements for Manuscripts
Submitted to Biomedical Journals: http://www.icmje.org/.
Abstracts. A structured abstract is required
for all regular clinical articles. The structured abstract, limited to 200 words, should contain all and only the following major headings: Objective; Methods; Results and Conclusion. The clinical trials registration should be included at the end of the abstract.
The Objective reflects the purpose of the study, that is, the hypothesis that is being tested. The Methods should include
the setting for the study, the subjects (number and type), the treatment or intervention, and the type of statistical analysis. The Results
include the outcome of the study and statistical significance, if appropriate. The Conclusion states the significance of the results.
A structured abstract not exceeding 200 words is required for systematic review articles (Background; Objectives; Search Strategy;
Selection criteria; Data collection and analysis; Main results; Conclusions).
Synopsis. The author should provide a one-
or two-sentence synopsis, no longer than 25 words, of the conclusions of the paper for use in the table of contents. No acronyms or
abbreviations may be included in the synopsis; these must be spelled out.
Acknowledgements. No personal acknowledgements
are allowed. Only funding organizations may be acknowledged.
Conflict of interest. Authors should disclose any conflicts of
interest, as described in the Author Guarantee Form, in a statement appearing before the references. If the authors have no conflicts
to disclose then this should also be stated.
References. References should not exceed 25 in number and should in general
be limited to the last decade. They must be numbered and listed as they are cited in the article, using Index Medicus abbreviations for
journal titles. They should accord with the system used in Uniform Requirements for Manuscripts Submitted to Biomedical Journals:
http://www.icmje.org/. List all authors, but if there are more than six, list first six plus et al. Include the volume and
issue numbers.
[1] Vellacott ID, Cooke EJ, James CE. Nausea and vomiting in early pregnancy. Int J Gynecol Obstet 1988;27(1):57-9.
[2] Speroff L, Glass BH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. Baltimore: Williams and Wilkins; 1982: 105.
[3] Disaia PJ, Creasman WT. Invasive cancer of the vulva In: Disaia PJ, Creasman WT, editors. Clinical Gynecologic Oncology. St. Louis:
C.V. Mosby; 1984: 214-219.
Text references should be indicated by Arabic numerals in brackets: 'the incidence is similar to that
in other reports [1,5,11,17]. Davies et al. [6] have reported ....' To avoid any delays in the editing process, authors must make every
effort to see that each reference is correct and complete. Incomplete references will be returned to the principal author for completion
before the manuscript is edited. All references must be in English. Citation information of those originally in other languages must
be translated into English in the reference list. This journal should be cited as Int J Gynecol Obstet.
Editorial style.
Arabic numerals should be used for weights, measures, percentages, and degrees of temperature. Weights and measures should be abbreviated
according to the International System of Units: kg, g, mg, ?g, mmol, ?mol; m, cm, mm, ?m, nm, A, cm2, mL, ?I;
M, mM, ?M, nM; N; h, min, s, ms, ?s. Use % after numerals throughout. Give generic names of all pharmaceutical preparations
and, where appropriate, include (in parentheses, following) the trade name and manufacturer's name and address. Give the manufacturer's
name and address (in parentheses) following names of any instruments or equipment cited by brand name. Manuscripts not adhering to Instructions
may be returned to author.
Tables. Each table should be titled, numbered (with Arabic numerals), and on a separate page. Only
standard, universally understood abbreviations should be used. Authors should prepare tabular material in an easily readable form, eliminating
tables presenting information that can easily be incorporated into the text. Tables should be referred to in the text as 'Table 1' etc.
and approximate position indicated.
Figures and Photographs. All illustrations (line drawings and photographs) should be submitted
as separate files, preferably in TIFF or JPEG format. Figures and photographs of good quality should be submitted online as a separate
file (no less than 300 dpi). Please use a lettering that remains clearly readable even after reduction to about 66%. For every figure
or photograph a legend should be provided; legends should be typed double-spaced and numbered consecutively in the order of their citation
using Arabic numerals. If you submit usable color figures, Elsevier will ensure that these figures appear free-of-charge in color in
the electronic version of your accepted paper, regardless of whether or not these illustrations are reproduced in color in the printed
version. Color illustrations can only be included in print if the Author contributes the additional cost of reproduction: you
will receive information regarding the costs from Elsevier after receipt of your accepted article. Please note that because of technical
complications that may arise by converting color figures to 'grey scale' (for the printed version, should you not opt for color in print),
you should submit in addition usable black and white figures corresponding to all color illustrations. All Authors wishing to use illustrations
already published must first obtain the permission of the
Author and publisher and/or copyright holders and give precise reference to
the original work. This permission must include the right to publish in electronic media. Advice on the preparation of electronic artwork
can be found at the following URL: www.elsevier.com/artworkinstructions.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an
e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files
themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version
7 (or higher) available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to annotate
PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return
them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark
the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the
pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text,
tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission
from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure
that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent
corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of
your article if no response is received.
Offprints
The corresponding author, at no cost, will be provided with a PDF file
of the article via e-mail. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal
cover image and a disclaimer outlining the terms and conditions of use. Additional paper offprints can be ordered by the authors. An
order form with prices will be sent to the corresponding author.
SUBMISSION CHECKLIST
Please check each
item to be certain that the article is in compliance with the formation and requirements of the International Journal of Gynecology & Obstetrics. The checklist is available online at submission and must be completed by the author(s) for inclusion in the record.
TYPE OF ARTICLE: Please specify Clinical Article, Brief Communication, Review Article.
TITLE PAGE: This page
should contain (a) title of the paper; (b) name(s) of author(s); (c) affiliation(s) of author(s); (d) full contact details of the corresponding
author; (e) 3-6 keywords; (f) synopsis.
WORD COUNT: Include word count on cover letter and title page of manuscript.
NUMBER
OF AUTHORS: Do not list more than six authors.
STRUCTURED ABSTRACT: The abstract should be no more than 200 words in length
for clinical articles and systematic reviews.
SYNOPSIS: Provide a one- or two-sentence synopsis no longer than 25 words of
the conclusions of the paper for the table of contents. Spell out all acronyms or abbreviations.
DRUG NAMES AND DOSAGES:
Review drug names and dosages with care.The author is responsible for all recommended dosages. Use only generic names of all
pharmaceutical preparations. The trade name and manufacturer's name and address may be included in parentheses following the first mention
of the drug in the article.
FIGURES AND TABLES: Check that all figures, legends, and tables are submitted. Legends should
be typed on a single separate page, figures and tables with Arabic numerals. Figures must be of publication quality, in black and white
or color.
REFERENCES: Please use the IJGO format (see full Instructions to Authors).
You should include no more than 25 references
for clinical articles or 40 for systematic reviews, limited, in general, to the last decade, and all in English.
NAME AND ADDRESS
FOR REPRINT REQUESTS: Use only initials, surname and mailing address. Do not include academic titles. To facilitate communication
regarding this article, please provide: E-mail; Tel. no; Fax no.
AUTHOR(S) GUARANTEE FORM: This form should accompany the
manuscript and include the full name of each author.
Funding body agreements and policies
Elsevier has established agreements
and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript
archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please
visit http://www.elsevier.com/fundingbodies
International Journal of Gynecology & Obstetrics has no
page charges.
|
| |
|
